GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nabriva Therapeutics NBRVF · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Nabriva Therapeutics

Our reporting

We have not reported on Nabriva Therapeutics yet.

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -16.75 a share on revenue of $2.3m.

Past results

Reported against what analysts expected

18 Oct 202329 Sept 202328 Aug 202331 Dec 202230 Sept 202230 Jun 2022
Earnings per share-3.73-3.73-2.72-7.32-4.21-4.38
Revenue—$2.6m$7.6m$10.4m$8.8m$8.8m

Key events

  1. 16 Sept 202225-to-1 reverse split
  2. 3 Dec 202010-to-1 reverse split
  3. 18 Sept 2015Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.